Health Care & Life Sciences » Pharmaceuticals | Acura Pharmaceuticals Inc.

Acura Pharmaceuticals Inc.

Acura Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.26
Market Cap
$5.66 M
Shares Outstanding
21.03 M
Public Float
7.21 M

Profile

Address
616 N. North Court
Palatine Illinois 60067
United States
Employees -
Website http://www.acurapharm.com
Updated 07/08/2019
Acura Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development, and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Financials

View All

Robert B. Jones
President, Chief Executive Officer & Director
George K. Ross
Independent Director